A team led by the UAB Institut de Neurociències (INc-UAB) has for the first time identified the mechanism behind a potentially fatal type of epilepsy, a symptom of mitochondrial diseases.

A research trial spearheaded by Merck hopes to change that — and Franciscan Health Indianapolis is at the forefront too, as it is the only hospital in Indiana selected to take part in the ...

A team led by the UAB Institut de Neurociències (INc-UAB) has for the first time identified the mechanism behind a potentially fatal type of epilepsy ...